Skip to main content
. 1998 Aug;36(8):2214–2219. doi: 10.1128/jcm.36.8.2214-2219.1998

TABLE 2.

Case control dataa

Variable S. schleiferi-infected patients Uninfected patients P S. aureus-infected patients P
No. of patients 6 24 15
Preoperative variables
 No. (%) of males 6 (100.0) 20 (83.3) 0.56 12 (80.0) 0.53
 Mean age (SD) 63.3 (6.9) 60.5 (11.4) 0.45 63.6 (12.3) 0.96
 Mean NYHA score (SD) 3.0 (1.1) 2.8 (1.3) 0.70 3.1 (0.9) 0.89
 Mean body mass index (SD) 24.8 (2.3) 26.6 (3.1) 0.15 26.5 (3.4) 0.20
 No. of diabetes mellitus patients 0 4 0.88 2 1.00
 No. of patients taking immunosuppressive drugs 0 1 1.00 1 1.00
Perioperative variables
 Mean duration of surgery (min) (SD) 217.2 (52.5) 219.9 (56.9) 0.91 243 (98.9) 0.44
 Mean duration of extracorporeal circulation (min) (SD) 112.0 (28.2) 113.1 (47.1) 0.94 135.7 (68.1) 0.29
 Mean amount of blood transfused (ml) (SD) 66.7 (163.3) 268.2 (464.4) 0.10 270.1 (139.2) 0.20
 Mean blood loss (ml) (SD) 550.0 (63.2) 569.1 (84.6) 0.56 743.5 (513.0) 0.17
 Mean no. of bypasses (SD) 3.7 (1.5) 2.7 (1.8) 0.21 3.7 (1.6) 1.00
 No. (%) of procedures with surgeon A 3 (50.0) 4 (16.6) 0.12 2 (13.3) 0.115
 No. (%) of procedures with anesthetist A 4 (66.6) 4 (16.6) 0.029 1 (6.6) 0.011
 No. (%) of procedures with OR nurse Ab 3 (50.0) 1 (4.2) 0.018 1 (6.6) 0.053
Postoperative variables
 Mean highest value of C-reactive protein (SD) 125.8 (61.2) 68.1 (54.0) 0.07 182.2 (122.8) 0.18
 Median length of stay (days) 27 11 0.003 26 0.98
a

P values represent comparisons between S. schleiferi-infected patients and uninfected patients and between S. schleiferi-infected patients and S. aureus-infected patients. 

b

OR, operating room.